Gastrointestinal Polyposis Syndromes
Gastrointestinal polyposis syndromes, including familial adenomatous polyposis (FAP) and Peutz-Jeghers syndrome, present significant risks for malignancy and require careful surveillance and management. This session focuses on the genetic, molecular, and clinical aspects of these syndromes, highlighting early detection, risk stratification, and therapeutic interventions. Participants will learn about endoscopic monitoring, surgical management, chemoprevention strategies, and emerging targeted therapies. The track also emphasizes the importance of genetic counseling, family screening, and patient education in reducing disease burden and improving outcomes.
Additionally, this session will explore translational research on novel biomarkers, molecular pathways, and gene-targeted interventions. Case studies and clinical experiences will illustrate challenges in early detection, polyp management, and cancer prevention. Attendees will gain insights into personalized approaches that integrate genetics, endoscopic surveillance, and surgical strategies, making this track an ideal platform for researchers, clinicians, and geneticists to present findings and share expertise.
Related Conference of Gastrointestinal Polyposis Syndromes
25th International Conference on Gastroenterology and Digestive Disorders
Gastrointestinal Polyposis Syndromes Conference Speakers
Recommended Sessions
- Advanced GI Endoscopy Techniques
- Alcoholic Liver Disease Studies
- Artificial Intelligence & Digital Health in GI
- Autoimmune Liver Disorders
- Bariatric Surgery & Obesity-Related GI Disorders
- Cholangiocarcinoma Research
- Clinical Trials & Translational Research
- Endoscopic Ultrasound (EUS) & Advanced Imaging
- Gastrointestinal Disorders: Clinical Updates
- Gastrointestinal Oncology
- Gastrointestinal Polyposis Syndromes
- Geriatric Gastroenterology & Liver Disorders
- GI Bleeding & Hemostasis Innovations
- Global Health & Public Health Challenges in GI & Liver
- Gut Microbiome & Therapeutics
- Hepatocellular Carcinoma & Liver Tumor Management
- Inflammatory Bowel Disease Research
- Liver Disease: Chronic and Acute Management
- Liver Transplantation Innovations
- Minimally Invasive Gastrointestinal Surgery
- Non-Alcoholic Fatty Liver Disease (NAFLD) & NASH
- Nutrition, Diet, and Lifestyle in GI & Liver Health
- Palliative Care & Quality of Life in GI & Liver Disorders
- Pediatric and Adult Liver Metabolic Disorders
- Pediatric Gastroenterology & Hepatology
- Pharmacology & Novel Therapeutics
- Precision Medicine & Biomarkers in Gastroenterology & Hepatology
- Rare GI & Liver Disorders
- Regenerative Medicine in Liver & GI Disorders
- Viral Hepatitis Research
Related Journals
Are you interested in
- Advances in Medical Imaging - Gastrosummit 2027 (France)
- Celiac Disease - Gastrosummit 2027 (France)
- Colorectal Diseases - Gastrosummit 2027 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - Gastrosummit 2027 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastrointestinal Bleeding - Gastrosummit 2027 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Pharmacology - Gastrosummit 2027 (France)
- Gastrointestinal Surgery - Gastrosummit 2027 (France)
- Geriatric Gastroenterology - Gastrosummit 2027 (France)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2027 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastrosummit 2027 (France)
- Liver Transplantation - Gastrosummit 2027 (France)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition in Digestive Health - Gastrosummit 2027 (France)
- Pancreatic Diseases - Gastrosummit 2027 (France)
- Pancreaticobiliary Disorders - Gastrosummit 2027 (France)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology - Gastrosummit 2027 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Precision Medicine in Digestive Diseases - Gastrosummit 2027 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Viral Hepatitis - Gastrosummit 2027 (France)
